Are you Dr. Rinehart?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 80 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
740 Rose St
Lexington, KY 40536Phone+1 859-323-5981Fax+1 859-257-6002
Summary
- Dr. John Rinehart, MD is an oncologist in Lexington, Kentucky. He is currently licensed to practice medicine in Kentucky, Alabama, and Texas. He is affiliated with UK HealthCare Good Samaritan Hospital and is a Professor at Kentucky.
Education & Training
Ohio State University HospitalResidency, Internal Medicine, 1972 - 1974
University of ChicagoResidency, Internal Medicine, 1971 - 1972- Ohio State University HospitalInternship, Internal Medicine, 1970 - 1971
- Ohio State University College of MedicineClass of 1970
Certifications & Licensure
KY State Medical License 2004 - 2025
OH State Medical License 1970 - 2018
AL State Medical License 1999 - 2004
TX State Medical License 1991 - 2003- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer Start of enrollment: 2002 Feb 01
- Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma Start of enrollment: 2005 Sep 01
- Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer Start of enrollment: 2005 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 101 citationsPretreatment with Dexamethasone Increases Antitumor Activity of Carboplatin and Gemcitabine in Mice Bearing Human Cancer Xenografts: In Vivo Activity, Pharmacokinetics...Hui Wang, Mao Li, John J. Rinehart, Ruiwen Zhang
Clinical Cancer Research. 2004-03-01 - 21 citationsEffect of HER2/neu Expression on Survival in Non–Small-Cell Lung CancerV. Korrapati, M. Gaffney, L. G. Larsson, L. Di Nunno, M. Riggs
Clinical Lung Cancer. 2001-02-01 - 188 citationsPhase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced CancersPatricia LoRusso, Smitha S. Krishnamurthi, John J. Rinehart, Lisle Nabell, Lisa Malburg
Clinical Cancer Research. 2010-03-15
Grant Support
- Dexamethasone/Carboplatin/Gemcitabine Untreated NsclcNational Center For Research Resources2004
- Core--Clinical TrialsNational Cancer Institute2000–2002
- Clinical Oncology Research Career Development ProgramNational Cancer Institute2000–2002
- Trial Of L-377202 Once Every Three WeeksNational Center For Research Resources2000
- Scott And White Community Clinical Oncology ProgramNational Cancer Institute1997
- Southwest Oncology GroupNational Cancer Institute1993–1997
- Chemotherapy And Biologics In A Murine Tumor ModelNational Cancer Institute1991
- Phase IB Trial Of IL-2 Alone Or With Cytotoxic CellsDivision Of Cancer Treatment1988–1990
Professional Memberships
- Member
